Director of BiostatisticsPfizer Inc.New York, New York
A biostatistician with more than 15 years of working experience in both the academia and pharmacological industry.
Disclosure information not submitted.
P-072 - A retrospective cohort study comparing persistence between rimegepant and oral triptans for the acute treatment of migraine in the United States.
POSTER ABSTRACT
P-103 - Satisfaction with treatment outcomes in people with migraine receiving rimegepant or triptans: a descriptive analysis from a real-world migraine tracking app
